New injection aims to starve breast cancer of hormones
NCT ID NCT06449027
Summary
This study is testing a new injectable medication called leuprolide emulsion for premenopausal women with hormone-sensitive breast cancer. The goal is to see if it safely and effectively lowers estrogen levels to help control cancer growth when given alongside standard hormone therapy. Researchers are comparing it to existing treatments to see if it works just as well.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER SUBJECTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, 200032, China
Conditions
Explore the condition pages connected to this study.